文献速递帕金森病与运动障碍

基底节萎缩作为X连锁肌张力障碍-帕金森综合征前驱期的标志物

Basal Ganglia Atrophy as a Marker for Prodromal X-Linked Dystonia-Parkinsonism.
PubMed 文献 · Ann Neurol · 2023-02-17

本研究对10例非显性携带者和24名健康对照进行双盲结构及铁敏感磁共振成像,并纳入17例患者验证。结果显示非显性携带者约10%、患者约40%存在纹状体和苍白球萎缩,患者黑质体积也约减少40%;尾状核体积与非显性携带者估计发病时间相关。结论认为基底节萎缩和铁沉积先于临床发病,可在估计发病前数年检测到。

要点

  • 非显性携带者已出现约10%的纹状体和苍白球萎缩。
  • 患者纹状体和苍白球萎缩约40%,黑质体积也约减少40%。
  • 非显性携带者尾状核体积与估计发病时间相关。

核心结论

  • 基底节萎缩和铁沉积先于X连锁肌张力障碍-帕金森综合征临床发病,可在估计发病前数年检测到。
  • 多模态成像有望识别临床未发病但已存在早期神经变性的突变携带者,并独立于临床指标监测疾病进展。
  • 需纵向研究进一步阐明前驱期X连锁肌张力障碍-帕金森综合征神经变性的起病和进展速度。

研究设计与样本

  • 双盲结构及铁敏感磁共振成像研究,纳入10例非显性携带者和24名健康对照。
  • 另招募17例X连锁肌张力障碍-帕金森综合征患者,用于重复验证既往基底节病理和铁积累的发现。
  • 使用六核苷酸扩增重复长度和3个与发病年龄相关的单核苷酸多态性估计非显性携带者和患者的发病年龄。

主要发现

  • 基于体素的形态学分析和皮层下体积测量显示,非显性携带者纹状体和苍白球萎缩约10%,患者约40%。
  • 患者黑质体积同样约减少40%。
  • 非显性携带者尾状核体积与估计发病时间相关。
  • 磁敏感加权成像证实患者壳核前内侧铁沉积;非显性携带者在降低统计阈值后,同一区域也显示小簇铁积累。

局限性

  • 需纵向研究进一步阐明前驱期X连锁肌张力障碍-帕金森综合征神经变性的起病和进展速度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In neurodegenerative diseases, the characterization of the prodromal phase is essential for the future application of disease-modifying therapies. X-linked dystonia-parkinsonism is a hereditary neurodegenerative movement disorder characterized by severe adult-onset dystonia accompanied by parkinsonism. Distinct striatal and pallidal atrophy is present already in early disease stages indicating a long-lasting presymptomatic degenerative process. To gain insight into the prodromal phase of X-linked dystonia-parkinsonism, structural and iron-sensitive magnetic resonance imaging (MRI) was performed in 10 non-manifesting carriers and 24 healthy controls in a double-blind fashion. Seventeen patients with X-linked dystonia-parkinsonism were recruited to replicate previous findings of basal ganglia pathology and iron accumulation. Age at onset was estimated in non-manifesting carriers and patients using the repeat length of the hexanucleotide expansion and 3 single-nucleotide polymorphisms associated with age at onset. Voxel-based morphometry and subcortical volumetry showed striatal and pallidal atrophy in non-manifesting carriers (~10%) and patients (~40%). Substantia nigra volume was similarly reduced in patients (~40%). Caudate volume correlated with time to estimated onset in non-manifesting carriers. Susceptibility-weighted imaging confirmed iron deposition in the anteromedial putamen in patients. Non-manifesting carriers also showed small clusters of iron accumulation in the same area after lowering the statistical threshold. In conclusion, basal ganglia atrophy and iron accumulation precede the clinical onset of X-linked dystonia-parkinsonism and can be detected years before the estimated disease manifestation. It thereby highlights the potential of multimodal imaging to identify clinically unaffected mutation carriers with incipient neurodegeneration and to monitor disease progression independent of clinical measures. Longitudinal studies are needed to further elucidate the onset and progression rate of neurodegeneration in prodromal X-linked dystonia-parkinsonism. ANN NEUROL 2023;93:999-1011.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Hanssen H, Diesta CCE, Heldmann M, et al. Basal Ganglia Atrophy as a Marker for Prodromal X-Linked Dystonia-Parkinsonism. Ann Neurol. 2023. PMID: 36646669. doi:10.1002/ana.26606

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。